Validation of HDAC6 and SIRT2 tubulin deacetylases as therapeutic targets for Huntington's disease
Since the identification of a widespread transcriptional dysregulation that occurs in Huntington's disease (HD), histone deacetylase (HDAC) inhibition has been explored as a possible therapeutic strategy for this devastating disease. Studies using broadrange acting HDAC inhibitors have shown gr...
Main Author: | Bobrowska, Anna |
---|---|
Published: |
King's College London (University of London)
2012
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.628114 |
Similar Items
-
Dysregulation of SIRT1 activity in the pathogenesis of Huntington's disease
by: Tulino, Raffaella
Published: (2015) -
Interrogation of Rab8 as a therapeutic target for Huntington's disease in Drosophila melanogaster
by: Delfino, Laura
Published: (2017) -
Psychological distress in the context of Huntington's disease
by: Theed, Rachael
Published: (2016) -
The ubiquitin proteasome system in Huntington's disease
by: Jolly, R. S.
Published: (2008) -
MRI and cognitive changes in Huntington's disease
by: Henley, Susie M. D.
Published: (2008)